Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions

